Random forest analysis of midbrain hypometabolism using [18F]-FDG PET identifies Parkinson’s disease at the subject-level
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Event
-
Veröffentlichung
- (where)
-
Marburg
- (who)
-
Philipps-Universität Marburg
- (when)
-
2024
- Creator
-
Ruppert-Junck, Marina Christine
Kräling, Gunter
Greuel, Andrea
Tittgemeyer, Marc
Timmermann, Lars
Drzezga, Alexander Eduard
Eggers, Carsten
Pedrosa, David
- DOI
-
10.3389/fncom.2024.1328699
- URN
-
urn:nbn:de:hebis:04-es2024-08659
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ruppert-Junck, Marina Christine
- Kräling, Gunter
- Greuel, Andrea
- Tittgemeyer, Marc
- Timmermann, Lars
- Drzezga, Alexander Eduard
- Eggers, Carsten
- Pedrosa, David
- Philipps-Universität Marburg
Time of origin
- 2024
Other Objects (12)
Modeling Parkinson’s disease in midbrain-like organoids
Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neurons
Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease
Modeling early phenotypes of Parkinson’s disease by age-induced midbrain-striatum assembloids
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Human midbrain organoids: a powerful tool for advanced Parkinson’s disease modeling and therapy exploration
Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons
Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons
Modeling Parkinson’s disease in midbrain-like organoids
Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neurons
Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease
Modeling early phenotypes of Parkinson’s disease by age-induced midbrain-striatum assembloids
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Human midbrain organoids: a powerful tool for advanced Parkinson’s disease modeling and therapy exploration
Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons
Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons
Modeling Parkinson’s disease in midbrain-like organoids
Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neurons
Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease
Modeling early phenotypes of Parkinson’s disease by age-induced midbrain-striatum assembloids
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Human midbrain organoids: a powerful tool for advanced Parkinson’s disease modeling and therapy exploration
Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons
Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia